AU6730500A - Medicinal composition for percutaneous/permucosal absorption - Google Patents

Medicinal composition for percutaneous/permucosal absorption

Info

Publication number
AU6730500A
AU6730500A AU67305/00A AU6730500A AU6730500A AU 6730500 A AU6730500 A AU 6730500A AU 67305/00 A AU67305/00 A AU 67305/00A AU 6730500 A AU6730500 A AU 6730500A AU 6730500 A AU6730500 A AU 6730500A
Authority
AU
Australia
Prior art keywords
percutaneous
medicinal composition
permucosal
absorption
permucosal absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67305/00A
Inventor
Masaki Hagiwara
Hiromi Hatano
Akio Kuwahara
Tadashi Ogawa
Hitoshi Yamauchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Pharma Chemical Co Ltd
Original Assignee
Fuji Chemical Industries Co Ltd
Fuji Chemical Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Chemical Industries Co Ltd, Fuji Chemical Industrial Co Ltd filed Critical Fuji Chemical Industries Co Ltd
Publication of AU6730500A publication Critical patent/AU6730500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
AU67305/00A 1999-08-25 2000-08-25 Medicinal composition for percutaneous/permucosal absorption Abandoned AU6730500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/238087 1999-08-25
JP23808799 1999-08-25
PCT/JP2000/005740 WO2001013938A1 (en) 1999-08-25 2000-08-25 Medicinal composition for percutaneous/permucosal absorption

Publications (1)

Publication Number Publication Date
AU6730500A true AU6730500A (en) 2001-03-19

Family

ID=17024977

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67305/00A Abandoned AU6730500A (en) 1999-08-25 2000-08-25 Medicinal composition for percutaneous/permucosal absorption

Country Status (2)

Country Link
AU (1) AU6730500A (en)
WO (1) WO2001013938A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6054400A (en) * 1983-09-01 1985-03-28 Grelan Pharmaceut Co Ltd Tetrapeptide
JPS6136298A (en) * 1984-07-27 1986-02-20 Kenji Suzuki Tripeptideamides
JPS62164693A (en) * 1986-01-17 1987-07-21 Mitsui Toatsu Chem Inc Tripeptide
SE9503924D0 (en) * 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
KR970701728A (en) * 1994-03-11 1997-04-12 스즈키 다다시 Peptide derivative
US6228841B1 (en) * 1995-09-11 2001-05-08 Daiichi Pharmaceutical Co., Ltd. Peptide derivatives
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
TW474945B (en) * 1997-12-26 2002-02-01 Daiichi Seiyaku Co Peptide derivatives having analgesic activity and capable of orally admistration
AU5446599A (en) * 1998-08-31 2000-03-21 Fuji Chemical Industries, Ltd. Peptide compounds

Also Published As

Publication number Publication date
WO2001013938A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HK1055739A1 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
AU2001296029A1 (en) Pharmaceutical preparation of percutaneous absorption type
AU5136998A (en) Medicinal composition
AU6122999A (en) Sorbefacients and preparations for percutaneous absorption containing the same
AU5326100A (en) Pharmaceutical compositions and methods for use
AU1887401A (en) Medicinal composition
AU2005300A (en) Medicinal compositions
AU1689999A (en) Medicinal composition for percutaneous administration
AU1574900A (en) Pharmaceutical compositions containing insulin
AU1986099A (en) Device for inhaling medicament
AU5286901A (en) Topical anesthetic formulation
AU5495798A (en) External preparations for percutaneous absorption
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
AU7936198A (en) Ketotifen preparation for percutaneous absorption
AU1732401A (en) Medicinal compositions for oral use
HK1024175A1 (en) Plasters for percutaneous absorption
AUPP332898A0 (en) Pharmaceutical composition
AU3192500A (en) Substituted proline derivatives and medicinal compositions containing the same
AU2940100A (en) Compositions for promoting percutaneous absorption
AU3074700A (en) Medicinal compositions with improved oral absorption
AU2882699A (en) Stabilizing composition for pharmaceutical dosage forms
AU4914400A (en) Novel pharmaceutical composition
AU8562998A (en) Idebenone-containing preparation for percutaneous administration

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase